By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ocular Therapeutix, Inc. 

204 Second Avenue

Waltham  Massachusetts  02451  U.S.A.
Phone: 781-895-3235 Fax: 781-895-3236



Company News
Ocular Therapeutix, Inc. (OCUL) Announces Exercise Of Over-Allotment Option 8/20/2014 11:05:54 AM
Ocular Therapeutix, Inc. (OCUL) Announces Closing Of Initial Public Offering 7/31/2014 10:54:12 AM
Ocular Therapeutix, Inc. (OCUL) To Ring The NASDAQ Stock Market Closing Bell 7/31/2014 10:48:15 AM
Massachusett's Ocular Therapeutix, Inc. (OCUL) Goes IPO At $13 A Share 7/25/2014 6:54:38 AM
Massachusett's Ocular Therapeutix, Inc. Sets Terms For $75 Million IPO 7/11/2014 7:57:12 AM
Ocular Therapeutix, Inc. To Present New Data On Sustained Release Drug Candidates Utilizing Proprietary Hydrogel Technology At The Association for Research in Vision & Ophthalmology Annual Meeting 4/28/2014 9:13:14 AM
Ocular Therapeutix, Inc. Begins Phase 3 Clinical Trial For Its Sustained Release Dexamethasone 3/17/2014 9:18:38 AM
Ocular Therapeutix, Inc. Receives FDA Approval For The ResureĀ® Sealant 1/9/2014 10:54:45 AM
Ocular Therapeutix, Inc. Announces Phase 2 Study Results for Sustained Release Dexamethasone 10/1/2013 10:54:14 AM
FDA Ophthalmic Devices Panel Favorably Votes for the Ocular Therapeutix, Inc.'s Resure® Sealant 9/20/2013 7:45:21 AM